Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Medigene AG 0QGJ.L
$1.63
-$0.05 (-2.98%)
На 18:02, 12 мая 2023
Ключевые показатели
-
Marketcap
41252904.00000000
-
week52high
2.93
-
week52low
1.68
-
Revenue
-
P/E TTM
0
-
Beta
0.88358700
-
EPS
-0.40600000
-
Last Dividend
0.28500000
-
Next Earnings Date
07 мая 2023 г. в 05:01
Описание компании
Medigene AG, a biotechnology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company is developing personalized T cell-based therapies with a focus on T cell receptor-modified T cells in the areas of unmet medical needs, which are in clinical development. It also focuses on dendritic cell vaccines and T cell-specific monoclonal antibodies. In addition, the company focuses on developing and marketing RhuDex for hepatology and gastroenterology indications. Medigene AG has a strategic partnership with 2seventy bio, Inc. for the development of T cell receptors. The company also has research collaboration agreements on novel cancer antigens for immunotherapies with the Université de Montréal; and with Cytovant Sciences Co. Ltd. It has operations in Europe, the United States, Asia, and internationally. The company was founded in 1994 and is headquartered in Munich, Germany.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии